Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like Time in Therapeutic Range (TTR) & SAMe-TT₂R₂ Warfarin vs DOAC Score frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the Time in Therapeutic Range (TTR) & SAMe-TT₂R₂ Warfarin vs DOAC Score?
The Time in Therapeutic Range (TTR) & SAMe-TT₂R₂ Warfarin vs DOAC Score is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in hematology practice. Computes anticoagulation control quality via Time in Therapeutic Range (TTR) and stratifies the likelihood of poor VKA response using the SAMe-TT₂R₂ score to determine when patients with atrial fibrillation or VTE should switch from Warfarin to a Direct Oral Anticoagulant (DOAC). Clinical scoring tools like Time in Therapeutic Range (TTR) & SAMe-TT₂R₂ Warfarin vs DOAC Score are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
Prevents preventable thromboembolic strokes and fatal hemorrhages by identifying patients failing vitamin K antagonist therapy who will benefit from modern DOACs.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate Time in Therapeutic Range (TTR) & SAMe-TT₂R₂ Warfarin vs DOAC Score:
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 1 | SAMe-TT₂R₂ Score 0–1: High Probability of Good Warfarin Control (TTR ≥ 70%) | green |
| ≥ 2 | SAMe-TT₂R₂ Score ≥ 2: Poor Warfarin Control Likely — DOAC Preferred | red |
When to Exercise Caution
TTR requires at least 3 to 6 months of consecutive INR records to calculate reliably via linear interpolation.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-08
Peer-Reviewed Medical Literature
- •Apostolakis S, et al. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. Chest. 2013;144(5):1555-1563.
- •Rosendaal FR, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236-239.
- •Joglar JA, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation. Circulation. 2024;149(1):e1-e156.
Related Hematology Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Hematology:
Body Surface Area (BSA)
Calculate BSA using the Mosteller formula.
CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
Calculates stroke risk for patients with atrial fibrillation.
HAS-BLED Score
Assesses bleeding risk in patients on anticoagulation therapy.
Ideal Body Weight (IBW)
Calculate ideal body weight using the Devine formula.
Mean Arterial Pressure (MAP)
Calculate MAP based on Systolic and Diastolic Blood Pressure.
HEART Score for Major Cardiac Events
Predicts 6-week risk of major adverse cardiac events (MACE).